Sagrera, M.; Garza-Moreno, L.; Cobos, À.; Llorens, A.M.; Huerta, E.; Pérez, M.; Pérez, D.; Espigares, D.; Segalés, J.; Sibila, M.
Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination. Vaccines 2025, 13, 1076.
https://doi.org/10.3390/vaccines13101076
AMA Style
Sagrera M, Garza-Moreno L, Cobos À, Llorens AM, Huerta E, Pérez M, Pérez D, Espigares D, Segalés J, Sibila M.
Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination. Vaccines. 2025; 13(10):1076.
https://doi.org/10.3390/vaccines13101076
Chicago/Turabian Style
Sagrera, Mònica, Laura Garza-Moreno, Àlex Cobos, Anna Maria Llorens, Eva Huerta, Mónica Pérez, Diego Pérez, David Espigares, Joaquim Segalés, and Marina Sibila.
2025. "Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination" Vaccines 13, no. 10: 1076.
https://doi.org/10.3390/vaccines13101076
APA Style
Sagrera, M., Garza-Moreno, L., Cobos, À., Llorens, A. M., Huerta, E., Pérez, M., Pérez, D., Espigares, D., Segalés, J., & Sibila, M.
(2025). Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination. Vaccines, 13(10), 1076.
https://doi.org/10.3390/vaccines13101076
